Sodium Oxybate Solution
NDC Package 65162-065-87
Package Information
Sodium Oxybate solution is a medication used to treat narcolepsy, a condition that causes severe daytime sleepiness. This formulation utilizes a solution delivery system. Marketed by Amneal Pharmaceuticals Llc, this product is identified by NDC 65162-065 and is authorized under FDA application ANDA203631.
Identification & Billing
- RxCUI: 349482 - sodium oxybate 500 MG in 1 mL Oral Solution
- RxCUI: 349482 - sodium oxybate 500 MG/ML Oral Solution
- RxCUI: 349482 - sodium oxybate 0.5 GM per 1 ML Oral Solution
- RxCUI: 349482 - sodium oxybate 500 MG per 1 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65162 - Amneal Pharmaceuticals Llc
- 65162-065 - Sodium Oxybate
- 65162-065-87 - 1 BOTTLE in 1 CARTON / 180 mL in 1 BOTTLE
- 65162-065 - Sodium Oxybate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65162-065-87 identifies a specific commercial package of 1 bottle in 1 carton / 180 ml in 1 bottle of Sodium Oxybate, a human prescription drug labeled by Amneal Pharmaceuticals Llc. This solution is formulated for oral use and contains sodium oxybate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amneal Pharmaceuticals Llc on September 12, 2025. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat narcolepsy, a condition that causes severe daytime sleepiness. Sodium oxybate can decrease daytime sleepiness and also reduce the number of sudden short attacks of weak/paralyzed muscles (known as cataplexy) that can occur in patients with narcolepsy. Sodium oxybate is a central nervous system depressant. It is also known as gamma hydroxybutyrate (GHB).
How is this Amneal Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65162006587. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.